Controversial role of bevacizumab in the development of venous thromboembolic events

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	3490
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	29
Issue number	25
DOIs	https://doi.org/10.1200/JCO.2011.36.5478
State	Published - Sep 1 2011

Access to Document

@article{597c15f32e164ad39add49cfea891b19,

title = "Controversial role of bevacizumab in the development of venous thromboembolic events",

author = "Sanjaykumar Hapani and Shenhong Wu",

year = "2011",

month = sep,

day = "1",

doi = "10.1200/JCO.2011.36.5478",

language = "English",

volume = "29",

pages = "3490",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "25",

}

TY - JOUR

T1 - Controversial role of bevacizumab in the development of venous thromboembolic events

AU - Hapani, Sanjaykumar

AU - Wu, Shenhong

PY - 2011/9/1

Y1 - 2011/9/1

UR - https://www.scopus.com/pages/publications/80052762628

U2 - 10.1200/JCO.2011.36.5478

DO - 10.1200/JCO.2011.36.5478

M3 - Letter

C2 - 21810676

AN - SCOPUS:80052762628

SN - 0732-183X

VL - 29

SP - 3490

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -